Trials / Completed
CompletedNCT01774864
Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction
Phase 3 Study to Evaluate the Efficacy and Safety of Once-a-day Dosing of Udenafil in the Treatment of Erectile Dysfunction
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 349 (actual)
- Sponsor
- Dong-A Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Study Design : multi-center, double-blind, placebo-controlled, randomized, parallel group, fixed dose design Phase : Phase III
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-8159 (Udenafil) | |
| DRUG | Placebo |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2013-01-24
- Last updated
- 2013-01-24
Source: ClinicalTrials.gov record NCT01774864. Inclusion in this directory is not an endorsement.